Hostname: page-component-cd9895bd7-gvvz8 Total loading time: 0 Render date: 2024-12-20T18:31:28.436Z Has data issue: false hasContentIssue false

1452 – Perimenopausal Depression: a Review

Published online by Cambridge University Press:  15 April 2020

E. Sesma
Affiliation:
Psychiatry, Hospital Universitario de Basurto, Bilbao, Spain
J. Finkle
Affiliation:
Psychiatry, University of Illinois at Chicago, Chicago, IL, USA
M.A. Gonzalez-Torres
Affiliation:
Neuroscience, The University of the Basque Country, Bilbao, Spain
M. Gaviria
Affiliation:
Psychiatry, University of Illinois at Chicago, Chicago, IL, USA

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

From adolescence, women have a 1.5 to 3 times higher risk than men of suffering from a depressive disorder. This risk increases in middle-aged of the life and even more in the transition period to menopause or perimenopause, when the depressive vulnerability becomes especially intense.

Objectives

To know more about depression in perimenopause.

Aims

To provide practitioners with accurate information about this condition thus helping to better recognition and treatment.

Methods

a selective literature review on the topic is performed.

Results

Hormonal, psychological and sociocultural factors have been suggested to understand the etiopathogeny of this condition. Treatment of depression in perimenopause is determined by the clinical severity and includes antidepressants, psychotherapy, and sometimes, hormone replacement therapy with estrogens.

Conclusions

Perimenopausal depression is an underdiagnosed and poorly treated problem, which generates a high level of suffering and deserves greater attention by clinicians and health systems.

Type
Abstract
Copyright
Copyright © European Psychiatric Association 2013
Submit a response

Comments

No Comments have been published for this article.